Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery Post author: Post published:March 20, 2024 Post category:uncategorized Post Content You Might Also Like Alarming increase in obesity-related cancers among young people in China August 23, 2024 Navigating the dual role of B cells in tumor immunity June 3, 2025 First-in-class cancer drug gamitrinib evaluated in phase 1 clinical trial June 2, 2026